Do analysts recommend SMTI or IINN?

Sanara MedTech currently has a consensus target price of $34.00, suggesting a potential upside of 33.02%. Given Sanara MedTech's stronger consensus rating and higher possible upside, equities research analysts plainly believe Sanara MedTech is more favorable than Inspira Technologies OXY B.H.N.. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanara MedTech 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.60 Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation and earnings, SMTI or IINN?

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than Sanara MedTech. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sanara MedTech $103.12M 2.27 -$37.56M -$3.77 N/A Inspira Technologies OXY B.H.N. $289K 109.60 -$13.22M N/A N/A

Do analysts recommend RXST or IINN?

RxSight currently has a consensus price target of $8.89, suggesting a potential upside of 71.27%. Given RxSight's stronger consensus rating and higher possible upside, research analysts clearly believe RxSight is more favorable than Inspira Technologies OXY B.H.N.. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RxSight 3 Sell rating(s) 7 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.92 Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, RXST or IINN?

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than RxSight. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio RxSight $134.48M 1.60 -$38.94M -$1.13 N/A Inspira Technologies OXY B.H.N. $289K 109.60 -$13.22M N/A N/A

Does the media prefer RXST or IINN?

In the previous week, RxSight had 3 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 4 mentions for RxSight and 1 mentions for Inspira Technologies OXY B.H.N.. RxSight's average media sentiment score of 1.23 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that RxSight is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RxSight 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inspira Technologies OXY B.H.N. 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate LUCD or IINN?

Lucid Diagnostics currently has a consensus target price of $4.19, indicating a potential upside of 361.38%. Given Lucid Diagnostics' stronger consensus rating and higher probable upside, research analysts clearly believe Lucid Diagnostics is more favorable than Inspira Technologies OXY B.H.N.. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lucid Diagnostics 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60 Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, LUCD or IINN?

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than Lucid Diagnostics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lucid Diagnostics $4.71M 39.13 -$58.01M -$0.47 N/A Inspira Technologies OXY B.H.N. $289K 109.60 -$13.22M N/A N/A

Is LUCD or IINN more profitable?

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Lucid Diagnostics' net margin of -876.72%. Company Net Margins Return on Equity Return on Assets Lucid Diagnostics -876.72% N/A -116.26% Inspira Technologies OXY B.H.N. N/A N/A N/A

Does the media prefer LUCD or IINN?

In the previous week, Lucid Diagnostics had 1 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 2 mentions for Lucid Diagnostics and 1 mentions for Inspira Technologies OXY B.H.N.. Lucid Diagnostics' average media sentiment score of 0.58 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Lucid Diagnostics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lucid Diagnostics 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Inspira Technologies OXY B.H.N. 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend FOCL or IINN?

FocalTherics presently has a consensus price target of $9.00, indicating a potential upside of 49.25%. Given FocalTherics' stronger consensus rating and higher probable upside, equities analysts plainly believe FocalTherics is more favorable than Inspira Technologies OXY B.H.N.. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score FocalTherics 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50 Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, FOCL or IINN?

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than FocalTherics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio FocalTherics $70.53M 3.20 -$29.25M -$0.81 N/A Inspira Technologies OXY B.H.N. $289K 109.60 -$13.22M N/A N/A

Does the media favor FOCL or IINN?

In the previous week, FocalTherics had 1 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 2 mentions for FocalTherics and 1 mentions for Inspira Technologies OXY B.H.N.. FocalTherics' average media sentiment score of 1.12 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that FocalTherics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment FocalTherics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inspira Technologies OXY B.H.N. 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend KRMD or IINN?

KORU Medical Systems presently has a consensus price target of $7.25, indicating a potential upside of 89.30%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, equities analysts plainly believe KORU Medical Systems is more favorable than Inspira Technologies OXY B.H.N.. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score KORU Medical Systems 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60 Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, KRMD or IINN?

KORU Medical Systems has higher revenue and earnings than Inspira Technologies OXY B.H.N.. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio KORU Medical Systems $41.13M 4.28 -$2.64M -$0.05 N/A Inspira Technologies OXY B.H.N. $289K 109.60 -$13.22M N/A N/A

Does the media favor KRMD or IINN?

In the previous week, KORU Medical Systems had 1 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 2 mentions for KORU Medical Systems and 1 mentions for Inspira Technologies OXY B.H.N.. KORU Medical Systems' average media sentiment score of 0.93 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that KORU Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KORU Medical Systems 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inspira Technologies OXY B.H.N. 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Inspira Technologies OXY B.H.N. (IINN) Competitors

$0.88 0.00 (-0.50%)

As of 07/24/2026

Compare

IINN vs. SMTI, RXST, LUCD, FOCL, and KRMD

Should you buy Inspira Technologies OXY B.H.N. stock or one of its competitors? MarketBeat compares Inspira Technologies OXY B.H.N. with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Inspira Technologies OXY B.H.N. include Sanara MedTech (SMTI), RxSight (RXST), Lucid Diagnostics (LUCD), FocalTherics (FOCL), and KORU Medical Systems (KRMD). These companies are all part of the "medical equipment" industry.

How does Inspira Technologies OXY B.H.N. compare to Sanara MedTech?

Sanara MedTech (NASDAQ:SMTI) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, risk, dividends, institutional ownership, media sentiment and profitability.

8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. 42.0% of Sanara MedTech shares are held by insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Sanara MedTech has a beta of 1.18, indicating that its stock price is 18% more volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, indicating that its stock price is 116% more volatile than the broader market.

Sanara MedTech currently has a consensus target price of $34.00, suggesting a potential upside of 33.02%. Given Sanara MedTech's stronger consensus rating and higher possible upside, equities research analysts plainly believe Sanara MedTech is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanara MedTech	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Sanara MedTech and Sanara MedTech both had 1 articles in the media. Sanara MedTech's average media sentiment score of 1.87 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Sanara MedTech is being referred to more favorably in the media.

Company	Overall Sentiment
Sanara MedTech	Very Positive
Inspira Technologies OXY B.H.N.	Neutral

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Sanara MedTech's net margin of -31.23%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Sanara MedTech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanara MedTech	-31.23%	-3.19%	-0.56%
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than Sanara MedTech.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanara MedTech	$103.12M	2.27	-$37.56M	-$3.77	N/A
Inspira Technologies OXY B.H.N.	$289K	109.60	-$13.22M	N/A	N/A

Summary

Sanara MedTech and Inspira Technologies OXY B.H.N. tied by winning 7 of the 14 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to RxSight?

RxSight (NASDAQ:RXST) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, valuation, institutional ownership and profitability.

RxSight currently has a consensus price target of $8.89, suggesting a potential upside of 71.27%. Given RxSight's stronger consensus rating and higher possible upside, research analysts clearly believe RxSight is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RxSight	3 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.92
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

RxSight has a beta of 1.15, suggesting that its stock price is 15% more volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, suggesting that its stock price is 116% more volatile than the broader market.

78.8% of RxSight shares are held by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. 10.1% of RxSight shares are held by insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, RxSight had 3 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 4 mentions for RxSight and 1 mentions for Inspira Technologies OXY B.H.N.. RxSight's average media sentiment score of 1.23 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that RxSight is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RxSight	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Inspira Technologies OXY B.H.N.	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than RxSight.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RxSight	$134.48M	1.60	-$38.94M	-$1.13	N/A
Inspira Technologies OXY B.H.N.	$289K	109.60	-$13.22M	N/A	N/A

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to RxSight's net margin of -36.58%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat RxSight's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RxSight	-36.58%	-17.01%	-15.12%
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A

Summary

RxSight and Inspira Technologies OXY B.H.N. tied by winning 7 of the 14 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Lucid Diagnostics?

Lucid Diagnostics (NASDAQ:LUCD) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, earnings and analyst recommendations.

Lucid Diagnostics has a beta of 1.07, suggesting that its stock price is 7% more volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, suggesting that its stock price is 116% more volatile than the broader market.

74.0% of Lucid Diagnostics shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 6.9% of Lucid Diagnostics shares are owned by insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Lucid Diagnostics had 1 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 2 mentions for Lucid Diagnostics and 1 mentions for Inspira Technologies OXY B.H.N.. Lucid Diagnostics' average media sentiment score of 0.58 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Lucid Diagnostics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lucid Diagnostics	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Inspira Technologies OXY B.H.N.	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Lucid Diagnostics' net margin of -876.72%.

Company	Net Margins	Return on Equity	Return on Assets
Lucid Diagnostics	-876.72%	N/A	-116.26%
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A

Lucid Diagnostics currently has a consensus target price of $4.19, indicating a potential upside of 361.38%. Given Lucid Diagnostics' stronger consensus rating and higher probable upside, research analysts clearly believe Lucid Diagnostics is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lucid Diagnostics	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than Lucid Diagnostics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lucid Diagnostics	$4.71M	39.13	-$58.01M	-$0.47	N/A
Inspira Technologies OXY B.H.N.	$289K	109.60	-$13.22M	N/A	N/A

Summary

Lucid Diagnostics beats Inspira Technologies OXY B.H.N. on 7 of the 13 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to FocalTherics?

FocalTherics (NASDAQ:FOCL) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations.

62.7% of FocalTherics shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 10.1% of FocalTherics shares are owned by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, FocalTherics had 1 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 2 mentions for FocalTherics and 1 mentions for Inspira Technologies OXY B.H.N.. FocalTherics' average media sentiment score of 1.12 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that FocalTherics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
FocalTherics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Inspira Technologies OXY B.H.N.	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to FocalTherics' net margin of -41.47%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat FocalTherics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FocalTherics	-41.47%	-137.61%	-40.62%
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than FocalTherics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FocalTherics	$70.53M	3.20	-$29.25M	-$0.81	N/A
Inspira Technologies OXY B.H.N.	$289K	109.60	-$13.22M	N/A	N/A

FocalTherics has a beta of -0.04, suggesting that its stock price is 104% less volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, suggesting that its stock price is 116% more volatile than the broader market.

FocalTherics presently has a consensus price target of $9.00, indicating a potential upside of 49.25%. Given FocalTherics' stronger consensus rating and higher probable upside, equities analysts plainly believe FocalTherics is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FocalTherics	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

FocalTherics beats Inspira Technologies OXY B.H.N. on 8 of the 15 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to KORU Medical Systems?

KORU Medical Systems (NASDAQ:KRMD) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations.

In the previous week, KORU Medical Systems had 1 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 2 mentions for KORU Medical Systems and 1 mentions for Inspira Technologies OXY B.H.N.. KORU Medical Systems' average media sentiment score of 0.93 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KORU Medical Systems	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Inspira Technologies OXY B.H.N.	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

KORU Medical Systems has a beta of 0.41, suggesting that its stock price is 59% less volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, suggesting that its stock price is 116% more volatile than the broader market.

KORU Medical Systems has higher revenue and earnings than Inspira Technologies OXY B.H.N..

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	4.28	-$2.64M	-$0.05	N/A
Inspira Technologies OXY B.H.N.	$289K	109.60	-$13.22M	N/A	N/A

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to KORU Medical Systems' net margin of -5.27%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-5.27%	-13.61%	-8.33%
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A

KORU Medical Systems presently has a consensus price target of $7.25, indicating a potential upside of 89.30%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, equities analysts plainly believe KORU Medical Systems is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

KORU Medical Systems beats Inspira Technologies OXY B.H.N. on 8 of the 14 factors compared between the two stocks.

Get Inspira Technologies OXY B.H.N. News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IINN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IINN vs. The Competition

Export

Metric	Inspira Technologies OXY B.H.N.	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$31.68M	$7.28B	$6.86B	$12.25B
Dividend Yield	N/A	1.33%	2.67%	9.79%
P/E Ratio	N/A	48.63	27.14	23.64
Price / Sales	109.60	96.85	517.01	89.03
Price / Cash	N/A	25.71	50.54	59.64
Price / Book	14.69	6.73	10.28	6.07
Net Income	-$13.22M	$162.27M	$3.60B	$331.99M
7 Day Performance	-30.62%	-5.05%	-1.27%	-0.63%
1 Month Performance	-48.17%	-5.86%	-0.37%	-2.00%
1 Year Performance	-37.51%	-2.88%	18.30%	13.62%

Inspira Technologies OXY B.H.N. Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IINN Inspira Technologies OXY B.H.N.	0.0131 of 5 stars	$0.88 -0.5%	N/A	-38.1%	$31.68M	$289K	N/A	20	High Trading Volume
SMTI Sanara MedTech	2.1257 of 5 stars	$24.52 +4.6%	$34.00 +38.7%	-0.4%	$214.90M	$103.12M	N/A	60
RXST RxSight	3.8246 of 5 stars	$5.25 +6.7%	$8.89 +69.3%	-34.6%	$203.67M	$134.48M	N/A	220
LUCD Lucid Diagnostics	3.1908 of 5 stars	$1.15 +15.0%	$4.19 +264.1%	-17.5%	$203.07M	$4.71M	N/A	70	High Trading Volume
FOCL FocalTherics	3.4147 of 5 stars	$5.46 +0.9%	$6.00 +9.9%	N/A	$202.97M	$74.07M	N/A	230	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IINN) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Inspira Technologies OXY B.H.N. (IINN) Competitors

IINN vs. SMTI, RXST, LUCD, FOCL, and KRMD

How does Inspira Technologies OXY B.H.N. compare to Sanara MedTech?

Summary

How does Inspira Technologies OXY B.H.N. compare to RxSight?

Summary

How does Inspira Technologies OXY B.H.N. compare to Lucid Diagnostics?

Summary

How does Inspira Technologies OXY B.H.N. compare to FocalTherics?

Summary

How does Inspira Technologies OXY B.H.N. compare to KORU Medical Systems?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IINN vs. The Competition

Inspira Technologies OXY B.H.N. Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Inspira Technologies OXY B.H.N. (IINN) Competitors

IINN vs. SMTI, RXST, LUCD, FOCL, and KRMD

How does Inspira Technologies OXY B.H.N. compare to Sanara MedTech?

Do institutionals & insiders have more ownership in SMTI or IINN?

Which has more volatility & risk, SMTI or IINN?

Do analysts recommend SMTI or IINN?

Does the media prefer SMTI or IINN?

Is SMTI or IINN more profitable?

Which has higher valuation and earnings, SMTI or IINN?

Summary

How does Inspira Technologies OXY B.H.N. compare to RxSight?

Do analysts recommend RXST or IINN?

Which has more volatility and risk, RXST or IINN?

Do institutionals and insiders hold more shares of RXST or IINN?

Does the media prefer RXST or IINN?

Which has preferable valuation & earnings, RXST or IINN?

Is RXST or IINN more profitable?

Summary

How does Inspira Technologies OXY B.H.N. compare to Lucid Diagnostics?

Which has more risk and volatility, LUCD or IINN?

Do insiders and institutionals have more ownership in LUCD or IINN?

Does the media prefer LUCD or IINN?

Is LUCD or IINN more profitable?

Do analysts rate LUCD or IINN?

Which has preferable valuation and earnings, LUCD or IINN?

Summary

How does Inspira Technologies OXY B.H.N. compare to FocalTherics?

Do insiders & institutionals believe in FOCL or IINN?

Does the media favor FOCL or IINN?

Is FOCL or IINN more profitable?

Which has higher valuation & earnings, FOCL or IINN?

Which has more risk and volatility, FOCL or IINN?

Do analysts recommend FOCL or IINN?

Summary

How does Inspira Technologies OXY B.H.N. compare to KORU Medical Systems?

Does the media favor KRMD or IINN?

Which has more risk and volatility, KRMD or IINN?

Which has higher valuation & earnings, KRMD or IINN?

Do insiders & institutionals believe in KRMD or IINN?

Is KRMD or IINN more profitable?

Do analysts recommend KRMD or IINN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IINN vs. The Competition

Inspira Technologies OXY B.H.N. Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools